Antiviral compounds

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9896433
SERIAL NO

14766646

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention discloses compounds of Formula I wherein the variables in Formula I are defined as described herein. Also disclosed are pharmaceutical compositions containing such compounds and methods for using the compounds of Formula I in the prevention or treatment of HCV infection.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
F HOFFMANN-LA ROCHE AGBASEL SUI BASEL BASEL-STADT

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chen, Zhi Livingston, US 223 2316
Chin, Elbert San Mateo, US 38 168
Erickson, Shawn David Leonia, US 41 305
Gabriel, Stephen Deems Winterville, US 14 64
Mertz, Eric Fair Lawn, US 31 94
Weikert, Robert James Clifton, US 37 233

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 20, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 20, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00